Germany Attention Deficit Hyperactivity Disorder Market Size & Outlook

The attention deficit hyperactivity disorder market in Germany is expected to reach a projected revenue of US$ 477.2 million by 2030. A compound annual growth rate of 3.9% is expected of Germany attention deficit hyperactivity disorder market from 2024 to 2030.
Revenue, 2023 (US$M)
$364.3
Forecast, 2030 (US$M)
$477.2
CAGR, 2024 - 2030
3.9%
Report Coverage
Germany

Germany attention deficit hyperactivity disorder market, 2018-2030 (US$M)

Germany

Related Markets

Germany attention deficit hyperactivity disorder market highlights

  • The Germany attention deficit hyperactivity disorder market generated a revenue of USD 364.3 million in 2023 and is expected to reach USD 477.2 million by 2030.
  • The Germany market is expected to grow at a CAGR of 3.9% from 2024 to 2030.
  • In terms of segment, stimulants was the largest revenue generating drug type in 2023.
  • Non-stimulants is the most lucrative drug type segment registering the fastest growth during the forecast period.


Attention deficit hyperactivity disorder market data book summary

Market revenue in 2023USD 364.3 million
Market revenue in 2030USD 477.2 million
Growth rate3.9% (CAGR from 2023 to 2030)
Largest segmentStimulants
Fastest growing segmentNon-stimulants
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationStimulants, Non-stimulants
Key market players worldwideEli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc


Other key industry trends

  • In terms of revenue, Germany accounted for 2.5% of the global attention deficit hyperactivity disorder market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany attention deficit hyperactivity disorder market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 337.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Attention Deficit Hyperactivity Disorder Market Companies

Name Profile # Employees HQ Website

Germany attention deficit hyperactivity disorder market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.


Stimulants was the largest segment with a revenue share of 70.96% in 2023. Horizon Databook has segmented the Germany attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.


Germany accounts for the largest share of the Europe attention deficit hyperactivity disorder market. The etiology of the disease is multifactorial, complex, and not yet fully understood. There is a genetic disposition, which is reflected in a familial accumulation of the disease.

The first choice of treatment prescribed in Germany is Ritalin in small doses, i.e., 5-10mg. The dose is increased progressively based on feedback from the patient. Methylphenidate was prescribed most frequently, followed by atomoxetine and lisdexamfetamine.

The pathogenesis of ADHD is not fully understood. The medical guideline recommends stimulants Ritalin (methylphenidate), amfetamine, and lisdexamfetamine) and nonstimulants (atomoxetine and guanfacine) as drug therapy in patients with ADHD. The approval status must be observed in each case. It must also be noted that stimulants are prescription narcotics under the Narcotics Act.

Reasons to subscribe to Germany attention deficit hyperactivity disorder market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Germany attention deficit hyperactivity disorder market databook

  • Our clientele includes a mix of attention deficit hyperactivity disorder market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Germany attention deficit hyperactivity disorder market , including forecasts for subscribers. This country databook contains high-level insights into Germany attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Germany attention deficit hyperactivity disorder market size, by drug type, 2018-2030 (US$M)

Germany Attention Deficit Hyperactivity Disorder Market Outlook Share, 2023 & 2030 (US$M)

Germany attention deficit hyperactivity disorder market size, by drug type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more